| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $32.1M | -53.6% |
| Cost of Revenue | $28.0M | +27.8% |
| Gross Profit | $4.2M | -91.2% |
| R&D Expense | $25.2M | +109.5% |
| SG&A Expense | $49.9M | +142.4% |
| Operating Income | -$156.7M | -349.4% |
| Interest Expense | $1.1M | -44.4% |
| Pre-tax Income | -$157.8M | -295.8% |
| Income Tax | $0 | — |
| Net Income | -$157.8M | -295.8% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $110.5M | -47.9% |
| Accounts Receivable | $12.5M | +230.8% |
| Inventory | $5.7M | +108.5% |
| Current Assets | $139.6M | -37.2% |
| Total Assets | $160.1M | -31.2% |
| Current Liabilities | $72.4M | +205.2% |
| Long-term Debt | $15.3M | +2.8% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$98.5M | -278.1% |
| Capital Expenditures | $882K | -45.7% |
| Investing Cash Flow | -$7.6M | -49.4% |
| Financing Cash Flow | $4.4M | -98.1% |
| Free Cash Flow | -$99.3M | -259.1% |
| Total Liabilities |
| $90.9M |
| +134.9% |
| Stockholders' Equity | $69.2M | -64.3% |